Healthcare >> Analyst Interviews >> January 3, 2000
ERIC W. COLDWELL is a member of Wachovia Securities' Healthcare Equity
Research team and his area of concentration includes pharmaceutical
outsourcing, life sciences, and eHealth and eResearch. Mr. Coldwell
graduated with honors from Wake Forest University in 1994 with a BA in
Political Science and as a member of Pi Sigma Alpha, the National
Political Science Honor Society. Mr. Coldwell is a graduate from the
evening MBA program at the Hugh McColl School of Business at Queens
College, and he is enrolled for Level II of the 2000 Chartered Financial
Analyst (CFA) program. Mr. Coldwell joined Interstate/Johnson Lane
(Wachovia Securities' predecessor prior to the April 1999 acquisition by
Wachovia Corp.) in May 1996 after working as an analyst for a regional
investment advisory firm. Initially, Mr. Coldwell served as IJL's
Investment Strategy Analyst, and then moved into Equity Research where
he assisted senior analysts in Pharmaceutical Outsourcing and Business
Services. Profile
are in pharmaceutical outsourcing.
Mr. Coldwell: Domestically, the largest players are Quintiles
Transnational (QTRN),
